- Home
- DERM vs EPIX Comparison
DERM vs EPIX Comparison
Compare DERM & EPIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DERM
- EPIX
- Stock Information
- Founded
- DERM 2014
- EPIX 2009
- Country
- DERM United States
- EPIX Canada
- Employees
- DERM N/A
- EPIX N/A
- Industry
- DERM Biotechnology: Pharmaceutical Preparations
- EPIX Biotechnology: Pharmaceutical Preparations
- Sector
- DERM Health Care
- EPIX Health Care
- Exchange
- DERM Nasdaq
- EPIX Nasdaq
- Market Cap
- DERM 95.0M
- EPIX 76.8M
- IPO Year
- DERM 2021
- EPIX N/A
- Fundamental
- Price
- DERM $5.19
- EPIX $1.72
- Analyst Decision
- DERM Strong Buy
- EPIX Hold
- Analyst Count
- DERM 3
- EPIX 3
- Target Price
- DERM $9.50
- EPIX $2.00
- AVG Volume (30 Days)
- DERM 55.0K
- EPIX 253.9K
- Earning Date
- DERM 03-20-2025
- EPIX 02-11-2025
- Dividend Yield
- DERM N/A
- EPIX N/A
- EPS Growth
- DERM N/A
- EPIX N/A
- EPS
- DERM N/A
- EPIX N/A
- Revenue
- DERM $57,771,000.00
- EPIX N/A
- Revenue This Year
- DERM N/A
- EPIX N/A
- Revenue Next Year
- DERM $36.49
- EPIX N/A
- P/E Ratio
- DERM N/A
- EPIX N/A
- Revenue Growth
- DERM N/A
- EPIX N/A
- 52 Week Low
- DERM $2.85
- EPIX $1.40
- 52 Week High
- DERM $6.89
- EPIX $9.92
- Technical
- Relative Strength Index (RSI)
- DERM 60.26
- EPIX 47.93
- Support Level
- DERM $4.85
- EPIX $1.69
- Resistance Level
- DERM $5.37
- EPIX $1.83
- Average True Range (ATR)
- DERM 0.40
- EPIX 0.07
- MACD
- DERM 0.02
- EPIX 0.01
- Stochastic Oscillator
- DERM 70.49
- EPIX 57.69
About DERM Journey Medical Corporation
Journey Medical Corp is a commercial stage pharmaceutical company focused on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions. The company's portfolio includes eight branded and three authorized generic prescription drugs for dermatological conditions that are marketed in the United States. Some of the group's products are Qbrexza, Accutane, Amzeeq, Exelderm and others.
About EPIX ESSA Pharma Inc.
ESSA Pharma Inc is a pharmaceutical company. The company is focused on the development of small-molecule drugs for the treatment of castration-resistant prostate cancer. It is developing drugs that selectively block the amino-terminal domain of the androgen receptor, potentially overcoming the known AR-dependent resistance mechanisms of CRPC and providing CRPC patients with the potential for increased progression-free and overall survival.